Unannounced Meal Handling of Advanced Closed Loop Insulin Delivery in Monitored Condition

  • STATUS
    Recruiting
  • participants needed
    16
  • sponsor
    Sheba Medical Center
Send
Updated on 19 February 2024
See if I qualify
insulin
type 1 diabetes mellitus

Summary

The study will follow participants for the periods of 3 months while using an advanced hybrid closed loop algorithm in free living conditions . Each period will have a different meal handling protocols. The objective is to identify the mitigation of the algorithm with different meal handling approaches.

Details
Condition Type1diabetes
Age 20-70 years
Treatment Advanced hybrid closed loop system
Clinical Study IdentifierNCT04479826
SponsorSheba Medical Center
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

b'Subject is 20 to 70 years of age at time of screening'
b"Subject's weight is between 50 and 120 kg"
b'A clinical diagnosis of Type 1 diabetes as determined by the Investigator for a'
b'minimum of 36 months prior to enrollment'
b'Subject has ongoing use of an insulin pump and rtCGM \\u2265 6 months prior to screening'
b'Subject has an A1C value \\u2264 10.0% demonstrated at the time of enrollment.'
b'Subject uses a rapid-acting analogue insulin in his/her pump'
b'Patient is willing to undergo all study procedures'
b'English proficiency'
b'Minimum daily insulin requirement (Total Daily Dose) of greater than or equal to 8'
b'units'

Exclusion Criteria

b'Female subject who has a positive serum pregnancy screening test, or who plans to'
b'become pregnant during the course of the study'
b'Subject has unresolved adverse skin condition, or unable to tolerate tape adhesive, in'
b'the area of sensor placement or device replacement (e.g., psoriasis, rash,'
b'Staphylococcus infection)'
b'Subject has a history of hypoglycemic seizure or hypoglycemic coma within the past 12'
b'months'
b'Subjects currently taking adjunct therapy with SGLT2-inhibitors, GLP-1 mimetics,'
b'Amylin.'
b'Subject has a history of seizure disorder unrelated to diabetes within the past 12'
b'months'
b'Gastroparesis, uncontrolled thyroid disorder, Addison dis. , Pituitary insufficiency'
b'Subject has a history of myocardial infarction, unstable angina, coronary artery'
b'bypass surgery, coronary artery stenting, transient ischemic attack (TIA),'
b'cerebrovascular accident (CVA), congestive heart failure, ventricular rhythm'
b'disturbances, or thromboembolic disease within the past 6 months'
b'Subject has a presence of a cardiac pacemaker or any other device that may be'
b'ensitive to radio frequency telemetry'
b'Subject has any condition, including screening lab values that in the opinion of the'
b'Investigator may preclude him/her from participating in the study and completing study'
b'related procedures'
b'Subject is actively participating in other investigational study (drug or device)'
b'Subjects who consume alcohol daily'
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

insulin
type 1 diabetes mellitus

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name
Edit Delete

Added by • 

 • 

Private

Edit Delete

Reply by • • Private
Edit Delete

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.